President Donald Trump announces he will nominate Dr. Heidi Overton, a physician and domestic policy aide, to lead the US Food and Drug Administration (FDA). Multiple outlets report the nomination follows Trump’s announcement on Truth Social and describes Overton as someone who has worked within his administration on health-related efforts.
The outlets also discuss Overton’s public positions and past statements. The Guardian and other sources characterize her as an abortion opponent, including her views on how abortion drugs should be regulated, specifically mifepristone. Business Day similarly describes her as opposing abortion rights and links her to the president’s broader health agenda and figures associated with it.
CBS and Fox focus more on the appointment itself, noting her role as a deputy assistant to the president for domestic policy and her selection to become FDA commissioner. Across coverage, the shared differences are in emphasis: some outlets foreground her abortion and drug-regulation views, while others highlight her job title and role in the administration’s health push.
